These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

51 related articles for article (PubMed ID: 3833348)

  • 1. Plasma levels of verapamil and its major metabolites during long-term oral treatment, in chronic stable angina. Correlation with the clinical effects of the drug.
    Zanolla L; Padrini R; Piovan D; Olivieri D; Zardini P
    Cardiologia; 1985 May; 30(5):369-73. PubMed ID: 3833348
    [No Abstract]   [Full Text] [Related]  

  • 2. Once-daily verapamil--an objective evaluation in stable angina pectoris using treadmill exercise testing.
    Raftery EB
    Br J Clin Pract Suppl; 1985 Jun; 42():17-23. PubMed ID: 3929824
    [No Abstract]   [Full Text] [Related]  

  • 3. [Antia-angina effect of verapamil through the clinical and ergometric evaluation].
    Castro I; Pereira FA; Rodrigues R
    Arq Bras Cardiol; 1977 Feb; 30 Suppl 1():75-7. PubMed ID: 329812
    [No Abstract]   [Full Text] [Related]  

  • 4. Prognostic implications of results from exercise testing in patients with chronic stable angina pectoris treated with metoprolol or verapamil. A report from the Angina Prognosis Study In Stockholm (APSIS).
    Forslund L; Hjemdahl P; Held C; Björkander I; Eriksson SV; Brodin U; Rehnqvist N
    Eur Heart J; 2000 Jun; 21(11):901-10. PubMed ID: 10806014
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Dazoxiben compared with verapamil in the treatment of stable angina pectoris evaluated by an exercise test].
    Mogensen F; Rasmussen V; Kjøller E; Knudsen JB; Gormsen J
    Ugeskr Laeger; 1985 Jul; 147(29):2299-302. PubMed ID: 3904110
    [No Abstract]   [Full Text] [Related]  

  • 6. An objective comparison of verapamil and placebo in chronic stable angina.
    Balasubramanian V; Raftery EB
    Clin Exp Pharmacol Physiol Suppl; 1982; 6():51-61. PubMed ID: 6811177
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Verapamil in the long-term treatment of angina pectoris.
    Raftos J
    Clin Exp Pharmacol Physiol Suppl; 1982; 6():43-9. PubMed ID: 6811176
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pharmacokinetics of verapamil and norverapamil during long-term oral therapy.
    Tartaglione TA; Pieper JA; Lopez LL; Mehta J
    Res Commun Chem Pathol Pharmacol; 1983 Apr; 40(1):15-27. PubMed ID: 6867470
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Age-related changes of antianginal effects of verapamil in patients with stable effort angina. A medium term randomized double-blind placebo controlled trial.
    Acanfora D; De Caprio L; Di Palma A; Lirato C; Parlati S; Furgi G; Guerra N; Odierna L; Nicolino A; Rengo F
    G Ital Cardiol; 1993 May; 23(5):451-8. PubMed ID: 8339870
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Clinical and cycloergometric evaluation of verapamil in the therapeutic of angina pectoris].
    Albuquerque DC; Schlesinger P; Benchimol CB; Albanesi FM; Benchimol AB
    Arq Bras Cardiol; 1977 Feb; 30 Suppl 1():65-70. PubMed ID: 329810
    [No Abstract]   [Full Text] [Related]  

  • 11. [Dynamics of the anti-anginal effect and of the concentrations of verapamil and its metabolites in the blood serum of patients with stenocardia of exertion].
    Slastnikova ID; Rumiantsev DO; Piotrovskiĭ VK; Riabokon' OS; Vygodin VA
    Kardiologiia; 1986 Jul; 26(7):60-5. PubMed ID: 3761829
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Comparative study of verapamil LI 120 mg 3 times a day and verapamil LP 120 mg twice a day in stable exertion-induced angina. A multicenter study].
    Belin A; Prost PL; Mercadier G; Grollier G; Lablanche JM
    Ann Cardiol Angeiol (Paris); 1995 Sep; 44(7):365-71. PubMed ID: 8561442
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Evaluation of the efficacy of verapamil in a slow-release preparation in the treatment of stable exertion angina].
    Scrutinio D; Lagioia R; De Toma L; Mangini S; Accettura D; De Nicolò M; Antuofermo F; Rizzon P
    Cardiologia; 1982 Oct; 27(10):963-71. PubMed ID: 6765260
    [No Abstract]   [Full Text] [Related]  

  • 14. The clinical and hemodynamic effects of propranolol, pindolol and verapamil in the treatment of exertional angina pectoris.
    Johnston DL; Manyari DE; Kostuk WJ
    Can Med Assoc J; 1984 Jun; 130(11):1449-55. PubMed ID: 6145515
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Haemodynamic dose-response effects of i.v. verapamil in coronary artery disease.
    Silke B; Verma SP; Ahuja RC; Nelson GI; Hussain M; Taylor SH
    Herz; 1984 Dec; 9(6):353-61. PubMed ID: 6510876
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Evaluation of the efficacy of verapamil in slow-release preparations in the treatment of stable exertion angina].
    Scrutinio D; Lagioia R; De Toma L; Mangini S; Accettura D; De Nicolò M
    Cardiologia; 1982 Oct; 27(10):963-71. PubMed ID: 6927458
    [No Abstract]   [Full Text] [Related]  

  • 17. [The ergometric test in the evaluation of the effects of nifedipine, verapamil and ethyl cinepazat maleate in angina of effort].
    Novo S; Davì G; Riolo F; Pinto A; Avellone G; Fazio M
    Boll Soc Ital Cardiol; 1980; 25(2):139-48. PubMed ID: 7236439
    [No Abstract]   [Full Text] [Related]  

  • 18. Disposition kinetics and urinary excretion of verapamil and some of its primary metabolites after oral administration in patients with angina pectoris.
    Piotrovskii VK; Rumiantsev DO; Nikolenko SA; Riabokon OS; Metelitsa VI
    Int J Clin Pharmacol Ther Toxicol; 1986 Jan; 24(1):4-11. PubMed ID: 3957489
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Acute and long-term effects of gallopamil (D 600) in stable angina pectoris--a randomized double-blind study].
    Rettig G; Sen S; Schieffer H; Bette L
    Z Kardiol; 1983 Dec; 72(12):746-54. PubMed ID: 6421002
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Verapamil and beta-adrenoceptor blockade in the treatment of stable angina pectoris.
    Hansen JF; Grytter C; Thomsen S; Sigurd B
    Clin Exp Pharmacol Physiol Suppl; 1982; 6():31-41. PubMed ID: 6126287
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.